tiprankstipranks
Trending News
More News >
GenSight Biologics SA (DE:G49N)
FRANKFURT:G49N
Germany Market
Advertisement

GenSight Biologics SA (G49N) Financial Statements

Compare
1 Followers

GenSight Biologics SA Financial Overview

GenSight Biologics SA's market cap is currently €19.10M. The company's EPS TTM is €-0.146; its P/E ratio is ―; GenSight Biologics SA is scheduled to report earnings on March 21, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 2.63M€ 1.27M€ 2.58M€ 5.28M€ 4.39M
Gross Profit€ 2.63M€ 3.00M€ 2.58M€ 5.28M€ 4.39M
Operating Income€ -15.81M€ -29.70M€ -27.84M€ -28.13M€ -24.93M
EBITDA€ -14.76M€ -21.73M€ -26.44M€ -26.83M€ -34.13M
Net Income€ -14.00M€ -26.22M€ -27.62M€ -28.62M€ -34.02M
Balance Sheet
Cash & Short-Term Investments€ 2.46M€ 2.13M€ 10.61M€ 44.29M€ 37.94M
Total Assets€ 10.76M€ 9.13M€ 25.94M€ 56.65M€ 47.36M
Total Debt€ 19.11M€ 18.43M€ 12.65M€ 12.57M€ 14.45M
Net Debt€ 16.65M€ 16.29M€ 2.04M€ -31.72M€ -23.49M
Total Liabilities€ 37.68M€ 39.83M€ 41.22M€ 40.66M€ 35.69M
Stockholders' Equity€ -26.92M€ -30.67M€ -15.28M€ 15.99M€ 11.67M
Cash Flow
Free Cash Flow€ -12.94M€ -24.67M€ -34.01M€ -17.17M€ -15.05M
Operating Cash Flow€ -12.94M€ -24.66M€ -33.75M€ -17.14M€ -15.04M
Investing Cash Flow€ 17.00K€ 209.00K€ 172.00K€ -16.00K€ -376.00K
Financing Cash Flow€ 13.54M€ 15.86M€ 95.00K€ 23.74M€ 33.86M
Currency in EUR

GenSight Biologics SA Earnings and Revenue History

GenSight Biologics SA Debt to Assets

GenSight Biologics SA Cash Flow

GenSight Biologics SA Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis